LTIP512A - Process for preparing pharmacological composition - Google Patents

Process for preparing pharmacological composition

Info

Publication number
LTIP512A
LTIP512A LTIP512A LTIP512A LTIP512A LT IP512 A LTIP512 A LT IP512A LT IP512 A LTIP512 A LT IP512A LT IP512 A LTIP512 A LT IP512A LT IP512 A LTIP512 A LT IP512A
Authority
LT
Lithuania
Prior art keywords
pharmacological composition
preparing
preparing pharmacological
composition
pharmacological
Prior art date
Application number
LTIP512A
Inventor
Maria Gazdag
Gabor Szepesi
Geza Takacsy-Nagy
Zsofia Papp
Laszlo Nagy
Eva Eszter Kiss
Monika Zsoldos
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of LTIP512A publication Critical patent/LTIP512A/en
Publication of LT3334B publication Critical patent/LT3334B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
LTIP512A 1989-11-07 1993-05-06 Process for preparing pharmacological composition LT3334B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU895804A HU204995B (en) 1989-11-07 1989-11-07 Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes

Publications (2)

Publication Number Publication Date
LTIP512A true LTIP512A (en) 1994-11-25
LT3334B LT3334B (en) 1995-07-25

Family

ID=10970758

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP512A LT3334B (en) 1989-11-07 1993-05-06 Process for preparing pharmacological composition

Country Status (37)

Country Link
US (1) US5397784A (en)
JP (1) JP3042702B2 (en)
KR (1) KR0164601B1 (en)
CN (1) CN1053569C (en)
AR (1) AR245592A1 (en)
AT (1) AT401469B (en)
AU (1) AU638504B2 (en)
BE (1) BE1004051A4 (en)
BG (1) BG60609B1 (en)
CA (1) CA2029368C (en)
CH (1) CH682130A5 (en)
CZ (1) CZ279433B6 (en)
DE (1) DE4035253B4 (en)
DK (1) DK266390A (en)
ES (1) ES2026062A6 (en)
FI (1) FI100455B (en)
FR (1) FR2653998B1 (en)
GB (1) GB2238241B (en)
GR (1) GR1001041B (en)
HU (1) HU204995B (en)
IE (1) IE62387B1 (en)
IL (1) IL96249A (en)
IT (1) IT1242724B (en)
LT (1) LT3334B (en)
LV (1) LV10687B (en)
MY (1) MY104595A (en)
NL (1) NL9002412A (en)
NO (1) NO175565C (en)
NZ (1) NZ236005A (en)
PL (1) PL164881B1 (en)
PT (1) PT95810B (en)
RU (1) RU1828401C (en)
SE (1) SE509715C2 (en)
SK (1) SK278421B6 (en)
UA (1) UA13162A (en)
YU (1) YU48373B (en)
ZA (1) ZA908855B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
JP2002100303A (en) * 2000-09-20 2002-04-05 Hitachi Ltd Color cathode-ray tube
US20050170015A1 (en) * 2000-10-31 2005-08-04 Brown Dennis M. Antiproliferative colchicine compositions and uses thereof
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (en) * 2003-12-23 2006-03-24 Pf Medicament PHARMACEUTICAL COMPOSITION OF VINFLUNIN FOR PARENTAL ADMINISTRATION, PROCESS FOR PREPARATION AND USE
US8512761B2 (en) 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
TWI678213B (en) * 2015-07-22 2019-12-01 美商史倍壯製藥公司 A ready-to-use formulation for vincristine sulfate liposome injection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD155034A1 (en) * 1980-07-31 1982-05-12 Uwe Olthoff METHOD FOR PRODUCING STABILIZED CALCIUM-CONTAINING INJECTION SOLUTIONS
IT1170152B (en) * 1982-07-19 1987-06-03 Lilly Co Eli IMPROVEMENTS TO OR CONCERNING VINCA-ALCALOID FORMULATIONS
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (en) * 1986-04-25 1989-06-02 Pf Medicament STABLE AQUEOUS SOLUTION OF VINCRISTINE SULFATE
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions

Also Published As

Publication number Publication date
RU1828401C (en) 1993-07-15
US5397784A (en) 1995-03-14
CZ540290A3 (en) 1994-11-16
FR2653998A1 (en) 1991-05-10
ES2026062A6 (en) 1992-04-01
IL96249A (en) 1995-07-31
KR0164601B1 (en) 1999-01-15
YU48373B (en) 1998-07-10
PL164881B1 (en) 1994-10-31
DK266390D0 (en) 1990-11-06
AU6584590A (en) 1991-05-16
SK540290A3 (en) 1997-05-07
JPH03206040A (en) 1991-09-09
CA2029368C (en) 2000-01-04
CN1053569C (en) 2000-06-21
AT401469B (en) 1996-09-25
IT1242724B (en) 1994-05-17
HUT55225A (en) 1991-05-28
LT3334B (en) 1995-07-25
GB2238241A (en) 1991-05-29
GR1001041B (en) 1993-03-31
IE903993A1 (en) 1991-05-08
GB2238241B (en) 1993-10-06
NZ236005A (en) 1992-03-26
PT95810B (en) 1997-11-28
BE1004051A4 (en) 1992-09-15
DE4035253A1 (en) 1991-05-08
CZ279433B6 (en) 1995-04-12
GB9024222D0 (en) 1990-12-19
MY104595A (en) 1994-04-30
FI100455B (en) 1997-12-15
ZA908855B (en) 1991-08-28
CA2029368A1 (en) 1991-05-08
FR2653998B1 (en) 1995-02-17
ATA223090A (en) 1996-02-15
NL9002412A (en) 1991-06-03
IT9067868A0 (en) 1990-11-06
GR900100795A (en) 1992-04-17
SK278421B6 (en) 1997-05-07
AU638504B2 (en) 1993-07-01
PT95810A (en) 1991-09-13
HU204995B (en) 1992-03-30
IT9067868A1 (en) 1992-05-06
NO175565C (en) 1994-11-02
IL96249A0 (en) 1991-08-16
UA13162A (en) 1997-02-28
CN1053185A (en) 1991-07-24
DE4035253B4 (en) 2004-10-07
NO904821D0 (en) 1990-11-06
BG60609B1 (en) 1995-10-31
NO904821L (en) 1991-05-08
HU895804D0 (en) 1990-01-28
SE9003523D0 (en) 1990-11-06
YU209590A (en) 1993-05-28
LV10687B (en) 1995-12-20
LV10687A (en) 1995-06-20
NO175565B (en) 1994-07-25
SE509715C2 (en) 1999-03-01
DK266390A (en) 1991-05-08
IE62387B1 (en) 1995-01-25
SE9003523L (en) 1991-05-08
FI905508A0 (en) 1990-11-07
AR245592A1 (en) 1994-02-28
JP3042702B2 (en) 2000-05-22
KR910009245A (en) 1991-06-28
CH682130A5 (en) 1993-07-30

Similar Documents

Publication Publication Date Title
YU99590A (en) Process for obtaining cephiriaxone
YU67290A (en) Process for preparing cephodizim-disodium
HU904920D0 (en) Process for producing neoalkyl-triol-triesthers
HU906464D0 (en) Process for producing chloro-fluoro-propanes
IL88943A0 (en) Process for preparing 1-alkyl-5-nitroimidazoles
GB2216519B (en) Process for preparing n-sulphonyl-ureas
LTIP512A (en) Process for preparing pharmacological composition
KR960009690B1 (en) Process for preparing polyarylenethioether
GB2222403B (en) Process for preparing 2-methoxyisobutylisonitrile
EP0418524A3 (en) Process for preparing amikacin
HUT54607A (en) Process for producing chloro-carboxylic acid-chlorides
HUT54096A (en) Process for producing fluoro-phenols
HUT55636A (en) Process for producing pharmaceutical composition
HUT61250A (en) Process for producing tetrathiocarbonates
EP0424921A3 (en) Process for preparing 21-desoxyprednisolone 17-esters
HUT53645A (en) Process for producing oxetanocyn g
EP0429077A3 (en) Process for producing inulooligosaccharides
HUT58281A (en) Process for producing 4-trans-/n-isopropyliden-amino/-cyclohexanol
YU81090A (en) Process for preparing polycyclical compounds
YU146589A (en) Process for preparing new alylaminoethyl-azoles
EP0433888A3 (en) Process for preparing polyalkylenglycolbisethers
HU904597D0 (en) Process for producing 2-fluo-1-olefines
YU87489A (en) Process for preparing felodipyn
IE890678L (en) Process for preparing n-sulphonyl-ureas
EP0405517A3 (en) Process for preparing bromodifluoroacetylfluoride

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20070506